Last reviewed · How we verify

Iota-Carrageenan — Competitive Intelligence Brief

Iota-Carrageenan (Iota-Carrageenan) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiviral polysaccharide. Area: Virology / Respiratory Infection.

marketed Antiviral polysaccharide Virology / Respiratory Infection Small molecule Live · refreshed every 30 min

Target snapshot

Iota-Carrageenan (Iota-Carrageenan) — NicOx. Iota-carrageenan is a natural polysaccharide that forms a protective physical barrier on nasal mucosa to trap and prevent viral particles from infecting respiratory epithelial cells.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Iota-Carrageenan TARGET Iota-Carrageenan NicOx marketed Antiviral polysaccharide

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiviral polysaccharide class)

  1. NicOx · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Iota-Carrageenan — Competitive Intelligence Brief. https://druglandscape.com/ci/iota-carrageenan. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: